Anti-SYT1/ P65/ SVP65 monoclonal antibody

Anti-SYT1/ P65/ SVP65 antibody for FACS & in-vivo assay

Target products collectionGo to SYT1/SYT1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1739-Ab-1/ GM-Tg-hg-MP1739-Ab-2Anti-Human SYT1 monoclonal antibodyHuman
GM-Tg-rg-MP1739-Ab-1/ GM-Tg-rg-MP1739-Ab-2Anti-Rat SYT1 monoclonal antibodyRat
GM-Tg-mg-MP1739-Ab-1/ GM-Tg-mg-MP1739-Ab-2Anti-Mouse SYT1 monoclonal antibodyMouse
GM-Tg-cynog-MP1739-Ab-1/ GM-Tg-cynog-MP1739-Ab-2Anti-Cynomolgus/ Rhesus macaque SYT1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1739-Ab-1/ GM-Tg-felg-MP1739-Ab-2Anti-Feline SYT1 monoclonal antibodyFeline
GM-Tg-cang-MP1739-Ab-1/ GM-Tg-cang-MP1739-Ab-2Anti-Canine SYT1 monoclonal antibodyCanine
GM-Tg-bovg-MP1739-Ab-1/ GM-Tg-bovg-MP1739-Ab-2Anti-Bovine SYT1 monoclonal antibodyBovine
GM-Tg-equg-MP1739-Ab-1/ GM-Tg-equg-MP1739-Ab-2Anti-Equine SYT1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1739-Ab-1/ GM-Tg-hg-MP1739-Ab-2; GM-Tg-rg-MP1739-Ab-1/ GM-Tg-rg-MP1739-Ab-2;
GM-Tg-mg-MP1739-Ab-1/ GM-Tg-mg-MP1739-Ab-2; GM-Tg-cynog-MP1739-Ab-1/ GM-Tg-cynog-MP1739-Ab-2;
GM-Tg-felg-MP1739-Ab-1/ GM-Tg-felg-MP1739-Ab-2; GM-Tg-cang-MP1739-Ab-1/ GM-Tg-cang-MP1739-Ab-2;
GM-Tg-bovg-MP1739-Ab-1/ GM-Tg-bovg-MP1739-Ab-2; GM-Tg-equg-MP1739-Ab-1/ GM-Tg-equg-MP1739-Ab-2
Products NameAnti-SYT1 monoclonal antibody
Formatmab
Target NameSYT1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SYT1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species SYT1/ P65/ SVP65 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLP002250human SYT1 Lentivirus particle
    ORF Viral VectorpGMLP002250human SYT1 Lentivirus plasmid
    ORF Viral VectorpGMLPm002510mouse Syt1 Lentivirus plasmid
    ORF Viral VectorvGMLPm002510mouse Syt1 Lentivirus particle


    Target information

    Target IDGM-MP1739
    Target NameSYT1
    Gene ID6857,20979,25716,695390,482579,654422,281511,100050526
    Gene Symbol and SynonymsBAGOS,G630098F17Rik,P65,SVP65,SYT,SYT1,SytI
    Uniprot AccessionP21579,P21707,P48018
    Uniprot Entry NameSYT1_HUMAN,SYT1_RAT,SYT1_BOVIN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000067715
    Target ClassificationN/A

    The target: SYT1, gene name: SYT1, also named as P65, SVP65, SYT. The synaptotagmins are integral membrane proteins of synaptic vesicles thought to serve as Ca(2+) sensors in the process of vesicular trafficking and exocytosis. Calcium binding to synaptotagmin-1 participates in triggering neurotransmitter release at the synapse (Fernandez-Chacon et al., 2001 [PubMed 11242035]).[supplied by OMIM, Jul 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.